Global 30-Day Morbidity and Mortality of Primary Bariatric Surgery Combined with Another Procedure: The BLEND Study.

Combined procedures Concomitant cholecystectomy Concomitant hiatal hernia repair Concomitant ventral hernia repair Primary bariatric and metabolic surgery

Journal

Obesity surgery

ISSN: 1708-0428

Titre abrégé: Obes Surg

Pays: United States

ID NLM: 9106714

Informations de publication

Date de publication:
13 Jun 2024

Historique:

received: 09 01 2024

accepted: 14 05 2024

revised: 14 05 2024

medline: 13 6 2024

pubmed: 13 6 2024

entrez: 13 6 2024

Statut: aheadofprint

Résumé

No robust data are available on the safety of primary bariatric and metabolic surgery (BMS) alone compared to primary BMS combined with other procedures. The objective of this study is to collect a 30-day mortality and morbidity of primary BMS combined with cholecystectomy, ventral hernia repair, or hiatal hernia repair. This is as an international, multicenter, prospective, and observational audit of patients undergoing primary BMS combined with one or more additional procedures. The audit took place from January 1 to June 30, 2022. A descriptive analysis was conducted. A propensity score matching analysis compared the BLEND study patients with those from the GENEVA cohort to obtain objective evaluation between combined procedures and primary BMS alone. A total of 75 centers submitted data on 1036 patients. Sleeve gastrectomy was the most commonly primary BMS (N = 653, 63%), and hiatal hernia repair was the most commonly concomitant procedure (N = 447, 43.1%). RYGB accounted for the highest percentage (20.6%) of a 30-day morbidity, followed by SG (10.5%). More than one combined procedures had the highest morbidities among all combinations (17.1%). Out of overall 134 complications, 129 (96.2%) were Clavien-Dindo I-III, and 4 were CD V. Patients who underwent a primary bariatric surgery combined with another procedure had a pronounced increase in a 30-day complication rate compared with patients who underwent only BMS (12.7% vs. 7.1%). Combining BMS with another procedure increases the risk of complications, but most are minor and require no further treatment. Combined procedures with primary BMS is a viable option to consider in selected patients following multi-disciplinary discussion.

Sections du résumé

BACKGROUND BACKGROUND

No robust data are available on the safety of primary bariatric and metabolic surgery (BMS) alone compared to primary BMS combined with other procedures.

OBJECTIVES OBJECTIVE

The objective of this study is to collect a 30-day mortality and morbidity of primary BMS combined with cholecystectomy, ventral hernia repair, or hiatal hernia repair.

SETTING METHODS

This is as an international, multicenter, prospective, and observational audit of patients undergoing primary BMS combined with one or more additional procedures.

METHODS METHODS

The audit took place from January 1 to June 30, 2022. A descriptive analysis was conducted. A propensity score matching analysis compared the BLEND study patients with those from the GENEVA cohort to obtain objective evaluation between combined procedures and primary BMS alone.

RESULTS RESULTS

A total of 75 centers submitted data on 1036 patients. Sleeve gastrectomy was the most commonly primary BMS (N = 653, 63%), and hiatal hernia repair was the most commonly concomitant procedure (N = 447, 43.1%). RYGB accounted for the highest percentage (20.6%) of a 30-day morbidity, followed by SG (10.5%). More than one combined procedures had the highest morbidities among all combinations (17.1%). Out of overall 134 complications, 129 (96.2%) were Clavien-Dindo I-III, and 4 were CD V. Patients who underwent a primary bariatric surgery combined with another procedure had a pronounced increase in a 30-day complication rate compared with patients who underwent only BMS (12.7% vs. 7.1%).

CONCLUSION CONCLUSIONS

Combining BMS with another procedure increases the risk of complications, but most are minor and require no further treatment. Combined procedures with primary BMS is a viable option to consider in selected patients following multi-disciplinary discussion.

Identifiants

DOI: 10.1007/s11695-024-07296-0 PMID: 38869833

pubmed: 38869833

doi: 10.1007/s11695-024-07296-0

pii: 10.1007/s11695-024-07296-0

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

Kloock S, Ziegler CG, Dischinger U. Obesity and its comorbidities, current treatment options and future perspectives: challenging bariatric surgery? Pharmacol Ther. 2023;251:108549. https://doi.org/10.1016/j.pharmthera.2023.108549 .

doi: 10.1016/j.pharmthera.2023.108549 pubmed: 37879540

Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022;18(12):1345–56. https://doi.org/10.1016/j.soard.2022.08.013 .

doi: 10.1016/j.soard.2022.08.013 pubmed: 36280539

Dorman RB, Zhong W, Abraham AA, et al. Does concomitant cholecystectomy at time of Roux-en-Y gastric bypass impact adverse operative outcomes? OBES SURG. 2013;23(11):1718–26. https://doi.org/10.1007/s11695-013-1001-4 .

doi: 10.1007/s11695-013-1001-4 pubmed: 23719861

Yardimci S, Coskun M, Demircioglu S, et al. Is concomitant cholecystectomy necessary for asymptomatic cholelithiasis during laparoscopic sleeve gastrectomy? OBES SURG. 2018;28(2):469–73. https://doi.org/10.1007/s11695-017-2867-3 .

doi: 10.1007/s11695-017-2867-3 pubmed: 28803397

Allatif REA, Mannaerts GHH, Al Afari HST, et al. Concomitant cholecystectomy for asymptomatic gallstones in bariatric surgery—safety profile and feasibility in a large tertiary referral bariatric center. OBES SURG. 2022;32(2):295–301. https://doi.org/10.1007/s11695-021-05798-9 .

doi: 10.1007/s11695-021-05798-9 pubmed: 34791618

Weiss AC, Inui T, Parina R, et al. Concomitant cholecystectomy should be routinely performed with laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2015;29(11):3106–11. https://doi.org/10.1007/s00464-014-4033-5 .

doi: 10.1007/s00464-014-4033-5 pubmed: 25515986

Dayan D, Dvir N, Nizri E, et al. Safety of concomitant cholecystectomy during one anastomosis gastric bypass compared with sleeve gastrectomy and Roux-en-Y gastric bypass. Updates Surg. 2023;75(3):671–8. https://doi.org/10.1007/s13304-023-01463-1 .

doi: 10.1007/s13304-023-01463-1 pubmed: 36790632

Sharma G, Boules M, Punchai S, et al. Outcomes of concomitant ventral hernia repair performed during bariatric surgery. Surg Endosc. 2017;31(4):1573–82. https://doi.org/10.1007/s00464-016-5143-z .

doi: 10.1007/s00464-016-5143-z pubmed: 27495345

Praveen Raj P, Senthilnathan P, Kumaravel R, et al. Concomitant laparoscopic ventral hernia mesh repair and bariatric surgery: a retrospective study from a tertiary care center. OBES SURG. 2012;22(5):685–9. https://doi.org/10.1007/s11695-012-0614-3 .

doi: 10.1007/s11695-012-0614-3 pubmed: 22328097

Praveenraj P, Gomes RM, Kumar S, et al. Concomitant bariatric surgery with laparoscopic intra-peritoneal onlay mesh repair for recurrent ventral hernias in morbidly obese patients: an evolving standard of care. OBES SURG. 2016;26(6):1191–4. https://doi.org/10.1007/s11695-015-1875-4 .

doi: 10.1007/s11695-015-1875-4 pubmed: 26337696

Krivan MS, Giorga A, Barreca M, et al. Concomitant ventral hernia repair and bariatric surgery: a retrospective analysis from a UK-based bariatric center. Surg Endosc. 2019;33(3):705–10. https://doi.org/10.1007/s00464-018-6492-6 .

doi: 10.1007/s00464-018-6492-6 pubmed: 30341658

Praveen Raj P, Bhattacharya S, Saravana Kumar S, et al. Morbid obesity with ventral hernia: is concomitant bariatric surgery with laparoscopic ventral hernia mesh repair the best approach? An experience of over 150 cases. Surg Obes Relat Dis. 2019;15(7):1098–103. https://doi.org/10.1016/j.soard.2019.04.027 .

doi: 10.1016/j.soard.2019.04.027 pubmed: 31201111

Marzouk AMSM, Ali HOE. Laparoscopic ventral hernia repair combined with sleeve gastrectomy in morbidly obese patients: early outcomes. Surg J (N Y). 2019;05(3):e87–91. https://doi.org/10.1055/s-0039-1694979 .

doi: 10.1055/s-0039-1694979

Dindo D, Demartines N, Clavien PA. Classification of surgical complications. Ann Surg. 2004;240(2):205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae .

doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123

von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9. https://doi.org/10.1016/j.jclinepi.2007.11.008 .

doi: 10.1016/j.jclinepi.2007.11.008

IBM Corp. Released 2020. IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp

Singhal R, Tahrani AA, Ludwig C, et al. Global 30-day outcomes after bariatric surgery during the COVID-19 pandemic (GENEVA): an international cohort study. Lancet Diabetes Endocrinol. 2021;9(1):7–9. https://doi.org/10.1016/S2213-8587(20)30375-2 .

doi: 10.1016/S2213-8587(20)30375-2 pubmed: 33253631

Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–107. https://doi.org/10.1002/sim.3697 .

doi: 10.1002/sim.3697 pubmed: 19757444 pmcid: 3472075

Normand ST, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54(4):387–98. https://doi.org/10.1016/s0895-4356(00)00321-8 .

doi: 10.1016/s0895-4356(00)00321-8 pubmed: 11297888

R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2019. https://www.R-project.org/ .

Ho D, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42:1–28. https://doi.org/10.18637/jss.v042.i08 .

doi: 10.18637/jss.v042.i08

Doulamis IP, Michalopoulos G, Boikou V, et al. Concomitant cholecystectomy during bariatric surgery: the jury is still out. Am J Surg. 2019;218(2):401–10. https://doi.org/10.1016/j.amjsurg.2019.02.006 .

doi: 10.1016/j.amjsurg.2019.02.006 pubmed: 30791992

ACS National Surgical Quality Improvement Program. ACS. Accessed December 5, 2023. https://www.facs.org/quality-programs/data-and-registries/acs-nsqip/

Falvo AM, Vacharathit V, Dove J, et al. A 3-Year MBSAQIP propensity-matched analysis of Roux-en-Y gastric bypass with concomitant cholecystectomy: is the robotic or laparoscopic approach preferred? Surg Endosc. 2021;35(8):4712–8. https://doi.org/10.1007/s00464-020-07939-0 .

doi: 10.1007/s00464-020-07939-0 pubmed: 32959181

Clapp B, Lee I, Liggett E, et al. Are concomitant operations during bariatric surgery safe? An analysis of the MBSAQIP database. OBES SURG. 2020;30(11):4474–81. https://doi.org/10.1007/s11695-020-04848-y .

doi: 10.1007/s11695-020-04848-y pubmed: 32712783

Moolla M, Dang J, Modasi A, et al. Concurrent laparoscopic ventral hernia repair with bariatric surgery: a propensity-matched analysis. J Gastrointest Surg. 2020;24(1):58–66. https://doi.org/10.1007/s11605-019-04291-0 .

doi: 10.1007/s11605-019-04291-0 pubmed: 31243713

Malaussena Z, Mhaskar R, Richmond N, et al. Hernia repair in the bariatric patient: a systematic review and meta-analysis. Surg Obes Relat Dis. Published online October 14, 2023:S1550–7289(23)00749–9. https://doi.org/10.1016/j.soard.2023.10.005

Lazzati A, Nassif GB, Paolino L. Concomitant ventral hernia repair and bariatric surgery: a systematic review. OBES SURG. 2018;28(9):2949–55. https://doi.org/10.1007/s11695-018-3366-x .

doi: 10.1007/s11695-018-3366-x pubmed: 29951782

Docimo S, Rahmana U, Bates A, et al. Concomitant hiatal hernia repair is more common in laparoscopic sleeve gastrectomy than during laparoscopic Roux-en-Y gastric bypass: an analysis of 130,772 cases. OBES SURG. 2019;29(2):744–6. https://doi.org/10.1007/s11695-018-3594-0 .

doi: 10.1007/s11695-018-3594-0 pubmed: 30536200

Chen W, Feng J, Wang C, et al. Effect of concomitant laparoscopic sleeve gastrectomy and hiatal hernia repair on gastroesophageal reflux disease in patients with obesity: a systematic review and meta-analysis. OBES SURG. 2021;31(9):3905–18. https://doi.org/10.1007/s11695-021-05545-0 .

doi: 10.1007/s11695-021-05545-0 pubmed: 34254259

Dakour Aridi HN, Tamim H, Mailhac A, et al. Concomitant hiatal hernia repair with laparoscopic sleeve gastrectomy is safe: analysis of the ACS-NSQIP database. Surg Obes Relat Dis. 2017;13(3):379–84. https://doi.org/10.1016/j.soard.2016.09.037 .

doi: 10.1016/j.soard.2016.09.037 pubmed: 27919836

Love MW, Verna DF, Kothari SN, et al. Outcomes of bariatric surgery with concomitant hiatal hernia repair using an absorbable tissue matrix. American Surgeon™. 2023;89(2):293–9. https://doi.org/10.1177/00031348211023450 .

doi: 10.1177/00031348211023450 pubmed: 34058829

Boru CE, Termine P, Antypas P, et al. Concomitant hiatal hernia repair during bariatric surgery: does the reinforcement make the difference? Minerva Surg. 2021;76(1):33–42. https://doi.org/10.23736/S2724-5691.20.08503-X .

doi: 10.23736/S2724-5691.20.08503-X pubmed: 33006451